INTOXICATE研究:前瞻性观察性研究的方法学与初步结果
INTOXICATE是由ESICM和EAPCCT支持的多中心前瞻性观察性研究,旨在建立中毒ICU患者实践数据库并确定「事件性入院」发生率。研究纳入78个ICU(主要来自欧洲,也有澳大利亚和东地中海地区)在2020年11月至2023年6月间的2273例急性中毒成人,中位年龄41岁,72%暴露于中毒药物。主要复合终点「事件性入院」发生率为68%(1546/2273),院内死亡率为4.5%(103/2273)。结论指出绝大多数患者存活,约三分之一患者在入ICU后未接受任何ICU特异性干预。
要点
- 主要终点「事件性入院」为复合终点,定义为入ICU后24小时内接受以下任一治疗或院内死亡:FiO2>40%的氧疗、机械通气、血管升压药、肾脏替代治疗(RRT)、心肺复苏、解毒剂、主动降温、液体复苏(>1.5 L任何种类静脉液体)、镇静。
- 78个ICU(主要来自欧洲,也有澳大利亚和东地中海地区)共纳入2273例急性中毒成人,中位年龄41岁,72%暴露于中毒药物。
- 事件性入院发生率为68%(1546/2273),即约三分之一患者入ICU后未接受任何ICU特异性干预。
- 院内死亡率为4.5%(103/2273),绝大多数患者存活。
适用人群与场景
- 急性中毒的成人ICU患者,纳入78个ICU(主要来自欧洲,也有澳大利亚和东地中海地区),2020年11月至2023年6月入组。
- 中位年龄41岁,72%暴露于中毒药物。
诊断标准与关键阈值
- 主要终点「事件性入院」为复合终点:入ICU后24小时内接受以下任一治疗或院内死亡——FiO2>40%的氧疗、机械通气、血管升压药、肾脏替代治疗(RRT)、心肺复苏、解毒剂、主动降温、液体复苏(>1.5 L任何种类静脉液体)、镇静。
研究设计与关键结果
- 研究类型:多中心前瞻性观察性研究,由ESICM和EAPCCT支持,共78个ICU参与,纳入2273例急性中毒成人。
- 主要终点:事件性入院发生率为68%(n=1546/2273)。
- 次要终点:院内死亡率为4.5%(n=103/2273)。
- 结论:绝大多数患者存活,约三分之一患者入ICU后未接受任何ICU特异性干预;已收集大样本急性中毒ICU患者的高质量详细临床数据,提供严重急性中毒需ICU入院的模式及结局信息。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is currently no practice-based, multicenter database of poisoned patients admitted to intensive care units (ICUs). The INTOXICATE study, endorsed by the ESICM and EAPCCT, aimed to determine the rate of eventful admissions among acutely intoxicated adult ICU patients.
METHODS: Ethical approval was obtained for this multicenter, prospective observational study, and data-sharing agreements were signed with each participating center. An electronic case report form was used to collect data on patient demographics, exposure, clinical characteristics, investigations, treatment, and in-hospital mortality data. The primary outcome, 'eventful admission', was a composite outcome defined as the rate of patients who received any of the following treatments in the first 24 h after the ICU admission: oxygen supplementation with a FiO2 > 40%, mechanical ventilation, vasopressors, renal replacement therapy (RRT), cardiopulmonary resuscitation, antidotes, active cooling, fluid resuscitation (> 1.5 L of intravenous fluid of any kind), sedation, or who died in the hospital.
RESULTS: Seventy-eight ICUs, mainly from Europe, but also from Australia and the Eastern Mediterranean, participated. A total of 2,273 patients were enrolled between November 2020 and June 2023. The median age of the patients was 41 years, 72% were exposed to intoxicating drugs. The observed rate of patients with an eventful ICU admission was 68% (n = 1546/2273 patients). The hospital mortality was 4.5% (n = 103/2273).
CONCLUSIONS: The vast majority of patients survive, and approximately one third of patients do not receive any ICU-specific interventions after admission in an intensive care unit for acute intoxication. High-quality detailed clinical data have been collected from a large cohort of acutely intoxicated ICU patients, providing information on the pattern of severe acute poisoning requiring intensive care admission and the outcomes of these patients.
TRIAL REGISTRATION: OSF registration ID: osf.io/7e5uy.
参考来源
- Zwaag SM, van den Hengel-Koot IS, Baker S, et al. The INTOXICATE study: methodology and preliminary results of a prospective observational study. Crit Care. 2024. PMID: 39334221. doi:10.1186/s13054-024-05096-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。